Wonkwang University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Iksan Korea, Republic of (1946)

Organization Overview

First Clinical Trial
2006
NCT00776828
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Department of anesthesiology and pain medicine, Wonkwang University Hospital | Gonyang University Hospital | Wonkwang Medical Center | Wonkwang UH | Wonkwang Univ. | Wonkwang University College of Medicine & Wonkwang University Sanbon Medical Center | Wonkwang University Guangju Medical Center | Wonkwang University Hospital | Wonkwang University Hospital of Korea | Wonkwang University Sanbon Medical Center | Wonkwang University School of Medicine & Hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 4)

Arthritis, Rheumatoid (Phase 4)

Atrial Fibrillation (Phase 3)

Back Pain (Phase 2)

Coronary Artery Disease (Phase 4)

Crohn Disease (Phase 4)

Depression (Phase 4)

Diabetic Retinopathy (Phase 4)

Dyspepsia (Phase 4)

Epilepsy (Phase 4)

Gastritis (Phase 3)

Hypertension (Phase 2)

Ischemia (Phase 4)

Joint Diseases (Phase 4)

Low Back Pain (Phase 2)

Macular Degeneration (Phase 4)

Microaneurysm (Phase 4)

Pain, Postoperative (Phase 4)

Reperfusion Injury (Phase 4)

Schizophrenia (Phase 1)

Stroke (Phase 3)

Wounds and Injuries (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 27
  • # of Trial APIs: 37